to Evaluate the Safety and Efficacy of Pitavastatin in Patients With IFG and Hyperlipidemia

A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 313 participants.

Also called NCT02056847

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; no masking; primary purpose treatment
Phase
Phase 4
Enrolled
  • 313 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT02056847
Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Countries
South Korea (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT02056847. Randomized; no masking; primary purpose treatment. Start 2013-09 (actual); primary completion 2017-05 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
to Evaluate the Safety and Efficacy of Pitavastatin in Patients With IFG and Hyperlipidemia
Acronym
SIPHON
Condition
HbA1c Level Associated With Lipid Compositions
Intervention (Drug)
Pitavastatin calcium 4mg
Intervention (Drug)
Pitavastatin calcium 2mg
Lead sponsor
JW Pharmaceutical (class: industry)
Collaborator
The Catholic University of Korea (class: other)
Collaborator
Kyunghee University Medical Center (class: other)
Collaborator
Korea University Guro Hospital (class: other)
Collaborator
Dong-A University Hospital (class: other)
Collaborator
Seoul National University Bundang Hospital (class: other)
Collaborator
Samsung Medical Center (class: other)
Collaborator
Seoul National University Hospital (class: other)
Collaborator
Ajou University School of Medicine (class: other)
Collaborator
Gangnam Severance Hospital (class: other)
Collaborator
Severance Hospital (class: other)
Collaborator
Yeungnam University Hospital (class: other)
Collaborator
Ulsan University Hospital (class: other)
Collaborator
Eulji University Hospital (class: other)
Collaborator
Asan Medical Center (class: other)
Collaborator
Chonnam National University Hospital (class: other)
Collaborator
Chonbuk National University Hospital (class: other)
Collaborator
Chungnam National University Hospital (class: other)
Collaborator
Hallym University Medical Center (class: other)

Registry records

Assembled by a program from ROR and ClinicalTrials.gov. No person wrote or checked these pages, and they are counted apart from the pages that people wrote. Lists of trials come from the registry's own coding and may miss trials.

Registry organizations 18

  • An organization that ClinicalTrials.gov lists as a sponsor or collaborator of 13 trials in this atlas.

    Organization

  • An organization that ClinicalTrials.gov lists as a sponsor or collaborator of 28 trials in this atlas.

    Organization03s5q0090

  • An organization that ClinicalTrials.gov lists as a sponsor or collaborator of 8 trials in this atlas.

    Organization

  • An organization that ClinicalTrials.gov lists as a sponsor or collaborator of 19 trials in this atlas.

    Organization00f200z37

  • An organization that ClinicalTrials.gov lists as a sponsor or collaborator of 6 trials in this atlas.

    Organization04353mq94

  • An organization that ClinicalTrials.gov lists as a sponsor or collaborator of 3 trials in this atlas.

    Organization05gcxpk23

  • An organization that ClinicalTrials.gov lists as a sponsor or collaborator of 12 trials in this atlas.

    Organization04ajwkn20

  • An organization that ClinicalTrials.gov lists as a sponsor or collaborator of 7 trials in this atlas.

    Organization05ydxj072

  • An organization that ClinicalTrials.gov lists as a sponsor or collaborator of 10 trials in this atlas.

    Organization

  • An organization that ClinicalTrials.gov lists as a sponsor or collaborator of 19 trials in this atlas.

    Organization0154bb690

Record details

Record id
cardio:ct-nct02056847
Content hash
5736ceda85135d1bb54623b2e48aac61310f51ffeec2dc6f51fd2cdc3f2ad1b7